Tonix Pharmaceuticals to Showcase Rheumatologic Research at EULAR 2025
Tonix Pharmaceuticals Holding Corp. is set to present its latest research at the Annual European Congress of Rheumatology (EULAR) 2025, highlighting advancements in rheumatologic conditions and its broader pipeline.
